Stroke therapy put to the test in preclinical randomized controlled trial

In the midst of what some call a ‘crisis’ in the ability to replicate results of laboratory studies, a European consortium has conducted a preclinical randomized controlled trial (pRCT) — which mimics the design and rigorous standards of a clinical trial but is done in animals, and provides one more view of the drug’s efficacy before it is used in the clinical trial setting.